The role of EMT and MET in cancer dissemination. (3rd September 2015)

• Record Type: Journal Article
• Authors: Banyard, Jacqueline; Bielenberg, Diane R.
• Is Part Of: Connective tissue research. Volume 56:Number 5(2015:Oct.)
• Page Start: 403
• Page End: 413
• Publication Date: 2015-09-03
• Subjects: Epithelial-mesenchymal transition -- exosomes -- hematogenous metastasis -- lymphogenous metastasis -- lymphatics -- microRNA; Connective tissues -- Periodicals; 616.770072
• DOI: 10.3109/03008207.2015.1060970
• Languages: English
• ISSNs: 0300-8207

Abstract

Abstract: Metastatic cancer cells are lethal. Understanding the molecular mechanisms that bolster the conversion from benign to malignant progression is key for treating these heterogeneous and resistant neoplasms. The epithelial-mesenchymal transition (EMT) is a conserved cellular program that alters cell shape, adhesion and movement. The shift to a more mesenchymal-like phenotype can promote tumor cell intravasation of surrounding blood vessels and emigration to a new organ, yet may not be necessary for extravasation or colonization into that environment. Lymphatic dissemination, on the other hand, may not require EMT. This review presents emerging data on the modes by which tumor cells promote EMT/MET via microRNA and prepare the pre-metastatic niche via exosomes.